RN

Rajeshkumar Nivrutti Kamble

Active Director Director DIN 10560870
DIN 10560870 First appointment Mar 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajeshkumar Nivrutti Kamble

Data last updated:

Rajeshkumar Nivrutti Kamble is a Director at Curezen Healthcare Private Limited (since 2024). The company operates in Paper.

DIN 10560870
Primary Designation Director
Industry Paper
First Appointment 22 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Curezen Healthcare Private Limited U21001MH2024PTC421982
Director22 Mar 20242024Active

Board colleagues of Rajeshkumar Nivrutti Kamble

Directorship timeline

Open interactive timeline →
Curezen Healthcare Private Limited
Premium access

Shareholding and investment profile for Rajeshkumar Nivrutti Kamble

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajeshkumar Nivrutti Kamble

Rajeshkumar Nivrutti Kamble currently holds 1 directorship: Curezen Healthcare Private Limited (Director, since 22 Mar 2024).

Rajeshkumar Nivrutti Kamble was first appointed on 22 Mar 2024 as Director at Curezen Healthcare Private Limited.

The current boards of Rajeshkumar Nivrutti Kamble's companies include Sanjay Mahadev Mulik (Curezen Healthcare Private Limited), Vijay Maruti Nayakawde (Curezen Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available